O	0	7	Results	Result	NNS	B-NP

O	8	11	The	The	DT	B-NP
O	12	23	observation	observation	NN	I-NP
O	24	28	that	that	IN	B-SBAR
O	29	31	AP	AP	NN	B-NP
O	31	32	-	-	HYPH	B-NP
O	32	33	3	3	CD	I-NP
O	34	36	is	be	VBZ	B-VP
O	37	42	found	find	VBN	I-VP
O	43	45	in	in	IN	B-PP
O	46	50	both	both	CC	B-NP
B-Organism_substance	51	60	cytosolic	cytosolic	JJ	I-NP
O	61	64	and	and	CC	O
B-Organism_substance	65	73	membrane	membrane	NN	B-NP
I-Organism_substance	74	85	subcellular	subcellular	JJ	I-NP
I-Organism_substance	86	95	fractions	fraction	NNS	I-NP
O	95	96	,	,	,	O
O	97	100	and	and	CC	O
O	101	105	that	that	IN	B-SBAR
B-Cellular_component	106	114	membrane	membrane	NN	B-NP
O	114	115	-	-	HYPH	B-VP
O	115	125	associated	associate	VBN	B-NP
O	126	128	AP	AP	NN	I-NP
O	128	129	-	-	HYPH	B-NP
O	129	130	3	3	CD	I-NP
O	131	134	can	can	MD	B-VP
O	135	137	be	be	VB	I-VP
O	138	147	extracted	extract	VBN	I-VP
O	148	152	with	with	IN	B-PP
O	153	158	salts	salt	NNS	B-NP
O	159	160	(	(	(	O
O	160	164	Dell	Dell	NNP	B-NP
O	164	165	'	'	POS	B-NP
O	165	173	Angelica	Angelica	NNP	I-NP
O	174	176	et	et	FW	I-NP
O	177	179	al	al	FW	I-NP
O	179	180	.	.	FW	I-NP
O	180	181	,	,	,	O
O	182	187	1997a	1997a	LS	B-LST
O	187	188	)	)	)	O
O	189	191	is	be	VBZ	B-VP
O	192	202	consistent	consistent	JJ	B-ADJP
O	203	207	with	with	IN	B-PP
O	208	211	its	its	PRP$	B-NP
O	212	216	role	role	NN	I-NP
O	217	219	as	as	IN	B-PP
O	220	221	a	a	DT	B-NP
B-Cellular_component	222	230	membrane	membrane	NN	I-NP
O	231	235	coat	coat	NN	I-NP
O	236	240	that	that	WDT	B-NP
O	241	244	can	can	MD	B-VP
O	245	247	be	be	VB	I-VP
O	248	257	recruited	recruit	VBN	I-VP
O	258	262	from	from	IN	B-PP
O	263	264	a	a	DT	B-NP
B-Organism_substance	265	274	cytosolic	cytosolic	JJ	I-NP
I-Organism_substance	275	279	pool	pool	NN	I-NP
O	279	280	.	.	.	O

O	281	283	In	In	IN	B-PP
O	284	292	addition	addition	NN	B-NP
O	292	293	,	,	,	O
O	294	297	the	the	DT	B-NP
O	298	306	punctate	punctate	NN	I-NP
O	307	315	staining	staining	NN	I-NP
O	316	318	of	of	IN	B-PP
O	319	321	AP	AP	NN	B-NP
O	321	322	-	-	HYPH	B-NP
O	322	323	3	3	CD	I-NP
O	324	326	by	by	IN	B-PP
O	327	345	immunofluorescence	immunofluorescence	NN	B-NP
O	346	356	microscopy	microscopy	NN	I-NP
O	356	357	,	,	,	O
O	358	361	its	its	PRP$	B-NP
O	362	376	redistribution	redistribution	NN	I-NP
O	377	379	to	to	TO	B-PP
O	380	383	the	the	DT	B-NP
B-Organism_substance	384	391	cytosol	cytosol	NN	I-NP
O	392	394	by	by	IN	B-PP
O	395	398	BFA	BFA	NN	B-NP
O	398	399	,	,	,	O
O	400	403	and	and	CC	O
O	404	407	the	the	DT	B-NP
O	408	421	reversibility	reversibility	NN	I-NP
O	422	424	of	of	IN	B-PP
O	425	428	the	the	DT	B-NP
O	429	432	BFA	BFA	NN	I-NP
O	433	439	effect	effect	NN	I-NP
O	440	441	(	(	(	O
O	441	445	Dell	Dell	NNP	B-NP
O	445	446	'	'	POS	B-NP
O	446	454	Angelica	Angelica	NNP	I-NP
O	455	457	et	et	FW	I-NP
O	458	460	al	al	FW	I-NP
O	460	461	.	.	FW	I-NP
O	461	462	,	,	,	O
O	463	468	1997a	1997a	CD	B-NP
O	468	469	;	;	:	O
O	470	477	Simpson	Simpson	NNP	B-NP
O	478	480	et	et	FW	I-NP
O	481	483	al	al	FW	I-NP
O	483	484	.	.	FW	I-NP
O	484	485	,	,	,	O
O	486	490	1997	1997	CD	B-NP
O	490	491	)	)	)	O
O	492	496	also	also	RB	B-ADVP
O	497	505	indicate	indicate	VBP	B-VP
O	506	510	that	that	IN	B-SBAR
O	511	513	AP	AP	NN	B-NP
O	513	514	-	-	HYPH	B-NP
O	514	515	3	3	CD	I-NP
O	516	519	can	can	MD	B-VP
O	520	525	cycle	cycle	VB	I-VP
O	526	533	between	between	IN	B-PP
O	534	537	the	the	DT	B-NP
B-Organism_substance	538	545	cytosol	cytosol	NN	I-NP
O	546	549	and	and	CC	I-NP
B-Cellular_component	550	559	membranes	membrane	NNS	I-NP
O	559	560	.	.	.	O

O	561	564	The	The	DT	B-NP
O	565	576	sensitivity	sensitivity	NN	I-NP
O	577	579	of	of	IN	B-PP
O	580	582	AP	AP	NN	B-NP
O	582	583	-	-	HYPH	B-NP
O	583	584	3	3	CD	I-NP
O	585	587	to	to	TO	B-PP
O	588	591	BFA	BFA	NN	B-NP
O	592	594	in	in	IN	B-PP
B-Cell	595	600	cells	cell	NNS	B-NP
O	601	609	suggests	suggest	VBZ	B-VP
O	610	614	that	that	IN	B-SBAR
O	615	618	its	its	PRP$	B-NP
B-Cellular_component	619	627	membrane	membrane	NN	I-NP
O	628	639	association	association	NN	I-NP
O	640	643	may	may	MD	B-VP
O	644	646	be	be	VB	I-VP
O	647	656	regulated	regulate	VBN	I-VP
O	657	659	by	by	IN	B-PP
O	660	664	ARF1	ARF1	NN	B-NP
O	664	665	,	,	,	O
O	666	671	since	since	IN	B-SBAR
O	672	675	BFA	BFA	NN	B-NP
O	676	684	inhibits	inhibit	VBZ	B-VP
O	685	689	ARF1	ARF1	NN	B-NP
O	690	697	guanine	guanine	NN	I-NP
O	698	708	nucleotide	nucleotide	NN	I-NP
O	709	717	exchange	exchange	NN	I-NP
O	717	718	,	,	,	O
O	719	722	and	and	CC	O
O	723	726	has	have	VBZ	B-VP
O	727	731	been	be	VBN	I-VP
O	732	737	shown	show	VBN	I-VP
O	738	740	to	to	TO	I-VP
O	741	748	prevent	prevent	VB	I-VP
O	749	753	ARF1	ARF1	NN	B-NP
B-Cellular_component	754	762	membrane	membrane	NN	I-NP
O	763	770	binding	binding	NN	I-NP
O	771	773	in	in	FW	B-ADVP
O	774	779	vitro	vitro	FW	I-ADVP
O	780	781	(	(	(	O
O	781	790	Donaldson	Donaldson	NNP	B-NP
O	791	793	et	et	FW	I-NP
O	794	796	al	al	FW	I-NP
O	796	797	.	.	FW	I-NP
O	797	798	,	,	,	O
O	799	803	1992	1992	CD	B-NP
O	803	804	;	;	:	O
O	805	810	Helms	Helms	NNP	B-NP
O	811	814	and	and	CC	I-NP
O	815	822	Rothman	Rothman	NNP	I-NP
O	822	823	,	,	,	O
O	824	828	1992	1992	CD	B-NP
O	828	829	;	;	:	O
O	830	838	Randazzo	Randazzo	NNP	B-NP
O	839	841	et	et	FW	I-NP
O	842	844	al	al	FW	I-NP
O	844	845	.	.	FW	I-NP
O	845	846	,	,	,	O
O	847	851	1993	1993	CD	B-NP
O	851	852	)	)	)	O
O	852	853	.	.	.	O

